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Background
The role of CD8+ T cells with cytotoxic (CTL) activity of
different HIV proteins in controlling HIV-1 infection is
still controversial, though a number of studies have sug-
gested that gag-specific CTLs could play a superior role in
viral control. The characterization of HIV-1-specific CTLs
in genetic diverse individuals infected with locally preva-
lent HIV-1 strains will provide useful information in elu-
cidating the mechanism of HIV-1 pathogenesis.
Methods
The HIV-1-specific CTLs were measured with an IFN-γ
ELISPOT assay by using overlapping peptides covering the
whole consensus clades B proteome in 114 untreated
HIV-1 clade B' infected Chinese. The correlation of CTL
responses with immune control of HIV-1 infection was
analyzed.
Results
The mean spot-forming cells/106  PBMCs of positive
responses to each of the HIV-1 proteins were as follows:
Gag, 2853; Pol, 1305; Env, 928; Nef, 1244; Tat, 543; Rev,
827; Vpr, 260; Vpu, 476 and Vif, 365. PBMC from 101/
114 (88.60%) subjects recognized at least one overlap-
ping Gag peptide. Pol, Env, Nef, Tat, Rev, Vpr, Vpu and Vif
were targeted by 85.09, 74.56, 78.95, 29.82, 29.82, 19.30,
12.28 and 32.46% of studied individuals, respectively.
When viral loads were compared to the proportion of pro-
tein-specific CTL responses of the total virus-specific
responses, we found an inverse association between viral
loads and the breadth (p < 0.001) and magnitude (p <
0.001) of the relative Gag response, and a direct associa-
tion between viral loads and the breadth of the relative
Tat(p = 0.029), Pol(p = 0.003) and Env(p = 0.029)
response and magnitude of the relative Tat(p = 0.043),
Pol(p = 0.003) and Env(p = 0.030) response.
Conclusion
In present study, Gag is the most immunodominant
region. The proportion of Gag-specific CTL responses
among the total virus-specific CTL activity is inversely
associated with viral loads. The dominance of Gag-specific
responses may be an indicator of relative control of HIV
infection.
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